Guanineâs proprietary technology amplifies and quantifies microbes including specific microbe strains, associated protein toxins, and drug resistant biomarkers, without enrichment or PCR using a rapid, simple and inexpensive platform. Patent pending innovation includes: Amplification of bioanalytes using amplification microbeads that replace optical labels with millions of electrochemically quantifiable tags per bioanalyte; Quantification of electrochemically tags with an electrochemical biosensor; Multiplex quantification using and bioanalyte-specific tags and bioanalyte-specific working electrodes. Rapid, simple and inexpensive test cycle that can be used for research applications in kits, or assays in POC cartridges, high throughput panels, and autonomous sensor stations Though the system can be used in numerous applications, a primary focus ison bacterias that are difficult to detect: multi-drug resistant organisms; hospital-acquired infection bacteria; microbiome organisms; biothreat agents and virulent food and environmental pathogen
